IVRTX | VGSIX | IVRTX / VGSIX | |
Total Expense Ratio | 1.15 | 0.27 | 426% |
Annual Report Gross Expense Ratio | 1.41 | 0.27 | 522% |
Fund Existence | 23 years | 29 years | - |
Gain YTD | 2.000 | 5.225 | 38% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 149M | 65.7B | 0% |
Annual Yield % from dividends | 2.56 | 3.71 | 69% |
Returns for 1 year | -4.66 | -2.24 | 208% |
Returns for 3 years | 18.11 | 28.83 | 63% |
Returns for 5 years | 11.32 | 35.79 | 32% |
Returns for 10 years | -2.56 | 57.04 | -4% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FXH | 111.66 | 0.71 | +0.64% |
First Trust Health Care AlphaDEX® ETF | |||
JPMB | 40.46 | 0.01 | +0.02% |
JPMorgan USD Emerging Mkts Svr Bd ETF | |||
APOC | 25.94 | N/A | +0.01% |
Innovator Eq Dfnd Prt ETF - 6 Mo Apr/Oct | |||
IEMG | 66.92 | -0.07 | -0.10% |
iShares Core MSCI Emerging Markets ETF | |||
DHY | 2.03 | -0.02 | -0.98% |
Credit Suisse High Yield |